Correlation between 1,5-anhydroglucitol and glycemic excursions in type 2 diabetic patients

Chinese Medical Journal

Volumn 124, Issue 22, 2011, Pages 3641-3645

  Sun, Jie ^a,b   Dou, Jing Tao ^a   Wang, Xian Ling ^a   Yang, Guo Qing ^a   Lü, Zhao Hui ^a   Zheng, Hua ^a   Ma, Fang Ling ^a   Lu, Ju Ming ^a   Mu, Yi Ming ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b Department of Endocrinology   (China)

Author keywords

1,5 anhydroglucitol; Glycemic excursions; Type 2 diabetes mellitus

Indexed keywords

1,5 ANHYDROSORBITOL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CHINESE; CONTINUOUS PROCESS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES CONTROL; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GLYCEMIC EXCURSION; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE;

AGED; BLOOD GLUCOSE; DEOXYGLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD;

EID: 82255169446     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.22.008     Document Type: Article

References (22)

1. Colette C, Monnier L. Acute glucose fluctuations and chronic sustained hyperglycemia as risk factors for cardiovascular diseases in patients with type 2 diabetes. Horm Metab Res 2007; 39: 683-686.
2. Quagliaro L, Piconi L, Assalone R, Martinelli L, Motz E, Ceriello A. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: The roll of protein kinase C and NAD(P)H-oxidase activation. Diabetes 2003; 52: 2795-2804.
3. DECODE Study Group, the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001; 161: 397-405.
4. Hanefeld M, Fischer S, Julius U, Schulze J, Schwanebeck U, Schmechel H, et al. DIS Group. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 1996; 39: 1577-1583.
5. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
6. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 2004; 141: 413-420.
7. Kishimoto M, Yamasaki Y, Kubota M. 1,5-Anhydro-D-glucitol evaluates daily glycemic excursions in well-controlled NIDDM. Diabetes Care 1995; 18: 1156-1159.
8. Dworacka M, Winiarska H. The application of plasma 1,5-anhydro-D-glucitol for monitoring type 2 diabetic patients. Dis Markers 2005; 21: 127-132.
9. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF, et al. Mean amplitude of glycemic excursion, a measure of diabetic instability. Diabetes 1970; 19: 644-655.
10. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006; 295: 1681-1687.
11. Molnar GD, Taylor WF, Ho MM. Day-to-day variation of continuously monitored glycaemia: a further measure of diabetic instability. Diabetologia 1972; 8: 342-348.
12. McCall AL, Cox DJ, Crean J, Gloster M, Kovatchev BP. A novel analytical method for assessing glucose variability: using CGMS in type 1 diabetes mellitus. Diabetes Technol Ther 2006; 8: 644-653.
13. Mastrototaro J. The MiniMed continuous glucose monitoring system (CGMS). J Pediatr Endocrinol Metab 1999; 12: 751-778.
14. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95 783 individuals followed for 12.4 years. Diabetes Care 1999; 22: 233-240.
15. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 2004; 141: 413-420.
16. Cavalot F, Petrelli A, Traversa M, Bonomo K, Fiora E, Conti M, et al. Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study. J Clin Endocrinol Metab 2006; 91: 813-819.
17. Schindhelm RK, Diamant M, Bilo HJ, Slingerland RJ. Association of 1,5-anhydroglucigtol and 2-h postprandial blood glucose in type 2 diabetic patients: Diabetes Care 2008; 31: e89.
18. Dungan K, Buse J, Largay J, Kelly M, Button E, Kato S, et al. 1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes. Diabetes Care 2006; 29: 1214-1219.
19. Dungan K, Buse J, Largay J, Kelly M, Button E, Kato S, et al. 1,5-anhydroglucitol (1,5-AG) and postprandial hyper-glycemia as measured by continous glucose monitoring system (CGMS) in inadequatedly controlled patients with diabetes. European Association for the study of Diabetes (EASD) Annual Meeting 2005 (Abstract 719).
20. Kawasaki I, Sato I, Hosoi M, Yoshioka K, Yamakita T, Fukumoto M, et al. Serum 1,5-anhydroglucitol is a strong predictor of the postprandial hyperglycemia in Type 2 diabetes patients (Abstract). Diabetes 2005; 54 (Supple 1): A76.
21. Kim MJ, Jung HS, Hwang-Bo Y, Cho SW, Jang HC, Kim SY, et al. Evaluation of 1,5-anhydroglucitol as a marker for glycemic variability in patients with type 2 diabetes mellitus. Acta Diabetol 2011; Jun 18: Epub ahead of print.
22. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ; A1C-Derived Average Glucose Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care 2008; 31: 1473-1478.